Veracyte, Inc.

General ticker "VCYT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.4B (TTM average)

Veracyte, Inc. follows the US Stock Market performance with the rate: 66.9%.

Estimated limits based on current volatility of 1.8%: low 29.97$, high 31.07$

Factors to consider:

  • Earnings expected soon, date: 2025-05-07 amc
  • US accounted for 95.0% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [26.97$, 47.31$]
  • 2025-12-31 to 2026-12-31 estimated range: [21.95$, 40.28$]

Financial Metrics affecting the VCYT estimates:

  • Positive: 0.04 < Non-GAAP EPS, $ of 0.83
  • Negative: Operating cash flow per share per price, % of 2.28 <= 7.09
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Industry operating income (median)
  • Negative: 0 < Inventory ratio change, % of 0.55
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Negative: Shareholder equity ratio, % of 90.46 > 63.75

Similar symbols

Short-term VCYT quotes

2025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062728293031323334
Price $

Long-term VCYT plot with estimates

202530354045Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.100.10.20.3
VCYTS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $296.54MM $361.05MM $445.76MM
Operating Expenses $337.62MM $446.85MM $429.62MM
Operating Income $-41.08MM $-85.80MM $16.14MM
Non-Operating Income $4.65MM $9.18MM $9.60MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $40.60MM $57.30MM $69.29MM
Income(Loss) $-36.43MM $-76.61MM $25.74MM
Taxes $0.13MM $-2.21MM $1.61MM
Profit(Loss)* $-36.56MM $-74.40MM $24.14MM
Stockholders Equity $1,075.20MM $1,044.10MM $1,175.97MM
Inventory $14.29MM $16.13MM $21.75MM
Assets $1,156.42MM $1,114.91MM $1,300.04MM
Operating Cash Flow $7.54MM $44.22MM $75.10MM
Capital expenditure $8.55MM $9.96MM $11.29MM
Investing Cash Flow $-29.39MM $15.11MM $-56.27MM
Financing Cash Flow $3.49MM $2.84MM $4.90MM
Earnings Per Share** $-0.51 $-1.02 $0.32

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.